Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT05512689
This study was a non-blinded, non-randomized intervention study in a single-center clinical setting, analyzing ventilation quality with and without RFM visibility.
Looking for future studies?
Notify MeUp to 12 month
All sexes
Interventional
Not applicable
Vienna, 1090, Austria
The study was conducted at the Neonatal Intensive Care Unit and the delivery room at the Division of Neonatology, at the Medical University of Vienna.
We aimed to record ventilation parameters (tidal volume, mask leak, ventilation rate, PIP, PEEP) using a CE-certified Respiratory Function Monitor (Neo100, Monivent AB, Gothenburg, Sweden), which was either hidden or visible to the provider responsible for the airway (airway provider), during ventilations on term and preterm patients at the NICU and the delivery room.
The investigators aimed to determine the quality of ventilations performed by healthcare professionals depending on RFM visibility. Analysis occurred, determining whether observing the data displayed on the RFM during PPV of preterm and newborn infants lead to adjustments in applied pressure and an increase in the proportion of inflations performed within a predefined range of 4-8 ml/kg for VTe.
The investigators hypothesized that using a RFM with numeric and graphical display of values during positive pressure ventilation of infants will lead to i) more frequent recognition and correction of tidal volumes outside the predefined range and ii) reduction of mask leak.
This knowledge gain may improve future training using a RFM to improve the quality of ventilations and, thereby, patient safety.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Healthcare professionals are able to use a feedback device to guide their ventilations.
Time frame: through study completion, an average of 1 year
percentage of ventilations within range divided through all ventilations performed, for each participant
Time frame: through study completion, an average of 1 year
defined as > 50%
Time frame: through study completion, an average of 1 year
defined as < 4ml/kg
Time frame: through study completion, an average of 1 year
defined as > 8ml/kg
Time frame: through study completion, an average of 1 year
defined as ventilations per minute
Time frame: through study completion, an average of 1 year
defined as > 35 cmH2O
Time frame: through study completion, an average of 1 year
this included diagnoses (i.e., bronchopulmonary dysplasia [BPD], persistent ductus arteriosus [PDA], IVH, periventricular leukomalacia [PVL], and pneumothorax) and the time frame of occurrence (within 24 hours, one week, or during the total hospital stay). BPD was defined as the need of any respiratory support at the GA of 36 weeks, evaluated for infants below 32+0 weeks GA. IVH was determined using the DEGUM classification
Time frame: through study completion, an average of 1 year
mean values for all evaluated ventilation parameters (VTe, leak, PIP, rate) for this comparison
Time frame: through study completion, an average of 1 year
mean values for all evaluated ventilation parameters (VTe, leak, PIP, rate) for this comparison
Time frame: through study completion, an average of 1 year
mean values for all evaluated ventilation parameters (VTe, leak, PIP, rate) for this comparison
Time frame: through study completion, an average of 1 year
mean values for all evaluated ventilation parameters (VTe, leak, PIP, rate) for this comparison
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03868319
Lung-protective Ventilation
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07239557
Atelectasis, Lung Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07123961
Acute Respiratory Distress Syndrome (ARDS), Lung Diseases
Philadelphia, Pennsylvania, United States
View Trial Details